A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Langmuir, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Feb 2020
- Primary completion
- 23 Feb 2023
- Completion
- 22 Aug 2023
- Last update posted
- 26 Mar 2024
- Registered enrollment
- 112
- Registry id
- NCT04071366
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.